Use of Neuromuscular Blocking and Antagonism Agents across the Spectrum of Renal Impairment Undergoing Major Inpatient Surgery: A Single-center Retrospective Observational Cohort Study.
作者信息
Colquhoun Douglas A, Kumar Sathish, Jewell Elizabeth, Mentz Graciela, Bickett-Hickok Ruth, Kheterpal Sachin
机构信息
University of Michigan, Ann Arbor, Michigan (D.A.C).
出版信息
Anesthesiology. 2024 Sep 1;141(3):602-607. doi: 10.1097/ALN.0000000000005079.
Abstract
摘要
相似文献
1
Use of Neuromuscular Blocking and Antagonism Agents across the Spectrum of Renal Impairment Undergoing Major Inpatient Surgery: A Single-center Retrospective Observational Cohort Study.在接受大型住院手术的不同程度肾功能损害患者中使用神经肌肉阻滞和拮抗药物：一项单中心回顾性观察队列研究。
Anesthesiology. 2024 Sep 1;141(3):602-607. doi: 10.1097/ALN.0000000000005079.
2
Neuromuscular Blockade and Antagonism in Patients with Renal Impairment: A Multicenter Retrospective Cross-sectional Study.肾功能损害患者的神经肌肉阻滞与拮抗作用：一项多中心回顾性横断面研究
Anesthesiology. 2025 Jun 1;142(6):1009-1024. doi: 10.1097/ALN.0000000000005411. Epub 2025 Feb 10.
3
Examining PACU Nurse Knowledge and Confidence of Neuromuscular Blocking Drugs and Neuromuscular Blocking Reversal Agents.考察麻醉后监护治疗病房护士对神经肌肉阻滞药物及神经肌肉阻滞逆转剂的知识掌握情况与信心水平。
J Perianesth Nurs. 2025 Aug;40(4):816-820.e1. doi: 10.1016/j.jopan.2024.09.018. Epub 2025 Jan 13.
4
Sugammadex or Neostigmine for prevention of post-operative pulmonary complications after major abdominal or thoracic surgery: study protocol for the SINFONIA (Sugammadex for preventioN oF pOst-operative pulmonary complIcAtions) randomised controlled superiority trial.舒更葡糖钠或新斯的明用于预防腹部或胸部大手术后的肺部并发症：SINFONIA（舒更葡糖钠预防术后肺部并发症）随机对照优势试验的研究方案
Trials. 2025 Aug 28;26(1):319. doi: 10.1186/s13063-025-08987-4.
5
Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries.神经肌肉阻滞、逆转剂使用情况及手术室时间：美国住院手术回顾性分析
Curr Med Res Opin. 2009 Apr;25(4):943-50. doi: 10.1185/03007990902769054.
6
Spontaneous recovery from neuromuscular block after a single dose of a muscle relaxant in pediatric patients: A systematic review using a network meta-analytic and meta-regression approach.小儿患者单次给予肌松药后神经肌肉阻滞的自发恢复：使用网络荟萃分析和荟萃回归方法的系统评价。
Paediatr Anaesth. 2024 Aug;34(8):720-733. doi: 10.1111/pan.14908. Epub 2024 Apr 26.
7
A Comparison Study of Major and Minor Complications After Inpatient Versus Outpatient Pediatric Brachial Plexus Surgery: A Preliminary Report.住院与门诊小儿臂丛神经手术后主要和次要并发症的比较研究：初步报告
J Pediatr Orthop. 2025 Sep 1;45(8):e733-e737. doi: 10.1097/BPO.0000000000002979. Epub 2025 Jul 21.
8
Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.在成人和青少年气管插管或直接喉镜检查期间，避免使用与使用神经肌肉阻滞剂以改善操作条件的比较。
Cochrane Database Syst Rev. 2017 May 17;5(5):CD009237. doi: 10.1002/14651858.CD009237.pub2.
9
Association between neuromuscular blocking agents and the development of intensive care unit-acquired weakness (ICU-AW): A systematic review with meta-analysis and trial sequential analysis.神经肌肉阻滞剂与重症监护病房获得性肌无力（ICU-AW）发展的相关性：系统评价与荟萃分析及试验序贯分析。
Anaesth Crit Care Pain Med. 2023 Jun;42(3):101202. doi: 10.1016/j.accpm.2023.101202. Epub 2023 Feb 16.
10
Physician anaesthetists versus non-physician providers of anaesthesia for surgical patients.外科患者的麻醉：医师麻醉师与非医师麻醉提供者的比较
Cochrane Database Syst Rev. 2014 Jul 11;2014(7):CD010357. doi: 10.1002/14651858.CD010357.pub2.
引用本文的文献
1
Neuromuscular Blockade and Antagonism in Patients with Renal Impairment: A Multicenter Retrospective Cross-sectional Study.肾功能损害患者的神经肌肉阻滞与拮抗作用：一项多中心回顾性横断面研究
Anesthesiology. 2025 Jun 1;142(6):1009-1024. doi: 10.1097/ALN.0000000000005411. Epub 2025 Feb 10.
本文引用的文献
1
A Dose-finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis.罗库溴铵拮抗的剂量探索：一项心脏手术患者和术后复发性神经肌肉阻滞监测的研究
Anesthesiology. 2023 Jul 1;139(1):6-15. doi: 10.1097/ALN.0000000000004578.
2
Muscle weakness after sugammadex: incomplete reversal of neuromuscular blockade or delayed postoperative recurarisation?使用舒更葡糖钠后的肌无力：神经肌肉阻滞未完全逆转还是术后肌松延迟恢复？
Br J Anaesth. 2023 Mar;130(3):e409-e412. doi: 10.1016/j.bja.2022.11.016. Epub 2022 Dec 29.
3
Electrolyte Changes in Contemporary Hemodialysis: A Secondary Analysis of the Monitoring in Dialysis (MiD) Study.当代血液透析中的电解质变化：透析监测（MiD）研究的二次分析。
Kidney360. 2021 Apr;2(4):695-707. doi: 10.34067/KID.0007452020. Epub 2021 Apr 29.
4
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程，无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
5
Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.Sugammadex 与新斯的明逆转神经肌肉阻滞和术后肺部并发症的比较（STRONGER）：一项多中心匹配队列分析。
Anesthesiology. 2020 Jun;132(6):1371-1381. doi: 10.1097/ALN.0000000000003256.
6
Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: a two-centre retrospective study.终末期肾病手术患者应用琥珀酸舒更葡糖钠的短期安全性和有效性：一项两中心回顾性研究。
Anaesthesia. 2020 Mar;75(3):348-352. doi: 10.1111/anae.14914. Epub 2019 Nov 12.
7
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.舒更葡糖钠与新斯的明在成人中逆转神经肌肉阻滞的疗效与安全性比较
Cochrane Database Syst Rev. 2017 Aug 14;8(8):CD012763. doi: 10.1002/14651858.CD012763.
8
Neuromuscular blocking drugs and their antagonists in patients with organ disease.患有器官疾病患者使用的神经肌肉阻滞剂及其拮抗剂。
Anaesthesia. 2009 Mar;64 Suppl 1:55-65. doi: 10.1111/j.1365-2044.2008.05871.x.
9
Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.多中心、平行组、对照试验，评估舒更葡糖钠在终末期肾衰竭患者或肾功能正常患者中的疗效和安全性。
Br J Anaesth. 2008 Oct;101(4):492-7. doi: 10.1093/bja/aen216. Epub 2008 Jul 23.
Zotero 插件